BIOMARIN PHARMACEUTICAL INC Deferred Tax Liabilities, Tax Deferred Income
BIOMARIN PHARMACEUTICAL INC (BMRN) had Deferred Tax Liabilities, Tax Deferred Income of $0 as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2022-02-25
- 2021-12-31: Deferred Tax Liabilities, Tax Deferred Income $0.00.
- 2020-12-31: Deferred Tax Liabilities, Tax Deferred Income $1.52M.
- 2019-12-31: Deferred Tax Liabilities, Tax Deferred Income $3.00M.
- 2018-12-31: Deferred Tax Liabilities, Tax Deferred Income $4.48M.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2020-12-31 | $1.52M 10-K · filed 2022-02-25 |
| 2019-12-31 | $3.00M 10-K · filed 2021-02-26 |
| 2018-12-31 | $4.48M 10-K · filed 2020-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |